Camfield P and Camfield C: Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 17:117–123. 2015.PubMed/NCBI

Carod-Artal FJ and Vázquez-Cabrera CB: An anthropological study about epilepsy in native tribes from Central and South America. Epilepsia. 48:886–893. 2007. View Article : Google Scholar : PubMed/NCBI

López González FJ, Rodríguez Osorio X, Gil-Nagel Rein A, Carreño Martínez M, Serratosa Fernández J, Villanueva Haba V, Donaire Pedraza AJ and Mercadé Cerdá JM: Drug-resistant epilepsy: Definition and treatment alternatives. Neurologia. 30:439–446. 2015.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J, Forsgren L, French JA, Glynn M, et al: ILAE official report: A practical clinical definition of epilepsy. Epilepsia. 55:475–482. 2014. View Article : Google Scholar : PubMed/NCBI

Golyala A and Kwan P: Drug development for refractory epilepsy: The past 25 years and beyond. Seizure. 44:147–156. 2017. View Article : Google Scholar : PubMed/NCBI

Falco-Walter JJ, Scheffer IE and Fisher RS: The new definition and classification of seizures and epilepsy. Epilepsy Res. 139:73–79. 2018. View Article : Google Scholar : PubMed/NCBI

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, et al: ILAE classification of the epilepsies: Position paper of the ILAE commission for classification and terminology. Epilepsia. 58:512–521. 2017. View Article : Google Scholar : PubMed/NCBI

Waldbaum S and Patel M: Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 88:23–45. 2010. View Article : Google Scholar : PubMed/NCBI

Carmona-Aparicio L, Pérez-Cruz C, Zavala-Tecuapetla C, Granados-Rojas L, Rivera-Espinosa L, Montesinos-Correa H, Hernández-Damián J, Pedraza-Chaverri J, Sampieri A III, Coballase-Urrutia E, et al: Overview of Nrf2 as therapeutic target in epilepsy. Int J Mol Sci. 16:18348–18367. 2015. View Article : Google Scholar : PubMed/NCBI

Cardenas-Rodriguez N, Coballase-Urrutia E, Pérez-Cruz C, Montesinos-Correa H, Rivera-Espinosa L, Sampieri A III and Carmona-Aparicio L: Relevance of the glutathione system in temporal lobe epilepsy: Evidence in human and experimental models. Oxid Med Cell Longev. 2014:7592932014. View Article : Google Scholar : PubMed/NCBI

Floriano-Sánchez E, Brindis F, Ortega-Cuellar D, Ignacio-Mejia I, Moreno-Arriola E, Romero-Morelos P, Ceballos-Vasquez E, Cordova-Espinoza MG, Arregoitia-Sarabia CK, Sandoval- Pacheco R, et al: Differential gene expression profile induced by valproic acid (VPA) in pediatric epileptic patients. Genes (Basel). 9(pii): E3282018. View Article : Google Scholar : PubMed/NCBI

Köhling R: Voltage-gated sodium channels in epilepsy. Epilepsia. 43:1278–1295. 2002. View Article : Google Scholar : PubMed/NCBI

Tan NC, Mulley JC and Berkovic SF: Genetic association studies in epilepsy: ‘The truth is out there’. Epilepsia. 45:1429–1442. 2004. View Article : Google Scholar : PubMed/NCBI

Semah F and Ryvlin P: Can we predict refractory epilepsy at the time of diagnosis? Epileptic Disord. 7 (Suppl 1):S10–S13. 2005.PubMed/NCBI

Fishman MC and Porter JA: Pharmaceuticals: A new grammar for drug discovery. Nature. 437:491–493. 2005. View Article : Google Scholar : PubMed/NCBI

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S and French J: Definition of drug resistant epilepsy: Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 51:1069–1077. 2010. View Article : Google Scholar : PubMed/NCBI

Kwan P and Brodie MJ: Early identification of refractory epilepsy. N Engl J Med. 342:314–319. 2000. View Article : Google Scholar : PubMed/NCBI

Brodie MJ, Barry SJ, Bamagous GA, Norrie JD and Kwan P: Patterns of treatment response in newly diagnosed epilepsy. Neurology. 78:1548–1554. 2012. View Article : Google Scholar : PubMed/NCBI

Picot MC, Baldy-Moulinier M, Daurès JP, Dujols P and Crespel A: The prevalence of epilepsy and pharmacoresistant epilepsy in adults: A population-based study in a Western European country. Epilepsia. 49:1230–1238. 2008. View Article : Google Scholar : PubMed/NCBI

Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW and Newton CR: Estimation of the burden of active and life-time epilepsy: A meta-analytic approach. Epilepsia. 51:883–890. 2010. View Article : Google Scholar : PubMed/NCBI

Zavala-Tecuapetla C, Sampieri A III, Calderón-Guzmán D and Carmona-Aparicio L: Principales mecanismos de acción farmacológica en las crisis epilépticas díficiles de estabilizar. Acta Pediátr México. 32:125–127. 2011.

Espinosa-Jovel CA and Sobrino-Mejia FE: Drug resistant epilepsy. Clinical and neurobiological concepts. Rev Neurol. 61:159–166. 2015.(In Spanish). PubMed/NCBI

Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, Gatti G, La Neve A, Muscas G, Specchio LM, et al: Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia. 52:2181–2191. 2011. View Article : Google Scholar : PubMed/NCBI

Argumosa A and Herranz J: La repercusión económica de las enfermedades crónicas: El coste de la epilepsia infantil en el año 2000. Bol Pediatr. 41:23–29. 2001.

Martin K, Jackson CF, Levy RG and Cooper PN: Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev. 2:CD0019032016.PubMed/NCBI

Chudomelova L, Scantlebury MH, Raffo E, Coppola A, Betancourth D and Galanopoulou AS: Modeling new therapies for infantile spasms. Epilepsia. 51 (Suppl 3):S27–S33. 2010. View Article : Google Scholar

Baumgartner C, Koren JP, Britto-Arias M, Zoche L and Pirker S: Presurgical epilepsy evaluation and epilepsy surgery. F1000Res. 8(pii): F1000 Faculty Rev-1818. 2019.PubMed/NCBI

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S and Pluta R: Ketogenic diet and epilepsy. Nutrients. 11(pii): E25102019. View Article : Google Scholar : PubMed/NCBI

Boon P, De Cock E, Mertens A and Trinka E: Neurostimulation for drug-resistant epilepsy: A systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response. Curr Opin Neurol. 31:198–210. 2018. View Article : Google Scholar : PubMed/NCBI

García-Contreras F, Constantino-Casas P, Castro-Ríos A, Nevárez-Sida A, Estrada Correa Gdel C, Carlos Rivera F, Guzmán-Caniupan J, Torres-Arreola Ldel P, Contreras- Hernández I, Mould-Quevedo J and Garduño-Espinosa J: Direct medical costs for partial refractory epilepsy in Mexico. Arch Med Res. 37:376–383. 2006. View Article : Google Scholar : PubMed/NCBI

Aguirre-Velázquez CG: Report from a survey of parents regarding the use of cannabidiol (Medicinal cannabis) in Mexican children with refractory epilepsy. Neurol Res Int. 2017:29857292017. View Article : Google Scholar : PubMed/NCBI

Younus I and Reddy DS: A resurging boom in new drugs for epilepsy and brain disorders. Expert Rev Clin Pharmacol. 11:27–45. 2018. View Article : Google Scholar : PubMed/NCBI

Tang F, Hartz AMS and Bauer B: Drug-resistant epilepsy: Multiple hypotheses, few answers. Front Neurol. 8:3012017. View Article : Google Scholar : PubMed/NCBI

Myers CT and Mefford HC: Advancing epilepsy genetics in the genomic era. Genome Med. 7:912015. View Article : Google Scholar : PubMed/NCBI

Depondt C: The potential of pharmacogenetics in the treatment of epilepsy. Eur J Paediatr Neurol. 10:57–65. 2006. View Article : Google Scholar : PubMed/NCBI

Mulley JC and Dibbens LM: Genetic variations and associated pathophysiology in the management of epilepsy. Appl Clin Genet. 4:113–125. 2011.PubMed/NCBI

Noebels J: Pathway-driven discovery of epilepsy genes. Nat Neurosci. 18:344–350. 2015. View Article : Google Scholar : PubMed/NCBI

Devinsky O: Patients with refractory seizures. N Engl J Med. 340:1565–1570. 1999. View Article : Google Scholar : PubMed/NCBI

Pal DK and Greenberg DA: Evaluating genetic heterogeneity in complex disorders. Hum Hered. 53:216–226. 2002. View Article : Google Scholar : PubMed/NCBI

Wang J, Wen Y, Zhang Q, Yu S, Chen Y, Wu X, Zhang Y and Bao X: Gene mutational analysis in a cohort of Chinese children with unexplained epilepsy: Identification of a new KCND3 phenotype and novel genes causing Dravet syndrome. Seizure. 66:26–30. 2019. View Article : Google Scholar : PubMed/NCBI

Fernández-Marmiesse A, Sánchez-Iglesias S, Darling A, O'Callaghan MM, Tonda R, Jou C and Araújo-Vilar D: A de novo heterozygous missense BSCL2 variant in 2 siblings with intractable developmental and epileptic encephalopathy. Seizure. 71:161–165. 2019. View Article : Google Scholar : PubMed/NCBI

Coughlin CR II, Swanson MA, Spector E, Meeks NJL, Kronquist KE, Aslamy M, Wempe MF, van Karnebeek CDM, Gospe SM Jr, Aziz VG, et al: The genotypic spectrum of ALDH7A1 mutations resulting in pyridoxine dependent epilepsy: A common epileptic encephalopathy. J Inherit Metab Dis. 42:353–361. 2019. View Article : Google Scholar : PubMed/NCBI

Angione K, Eschbach K, Smith G, Joshi C and Demarest S: Genetic testing in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 150:70–77. 2019. View Article : Google Scholar : PubMed/NCBI

Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, et al: Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain. 140:1316–1336. 2017. View Article : Google Scholar : PubMed/NCBI

Kang JQ and Macdonald RL: Molecular pathogenic basis for GABRG2 mutations associated with a spectrum of epilepsy syndromes, from generalized absence epilepsy to dravet syndrome. JAMA Neurol. 73:1009–1016. 2016. View Article : Google Scholar : PubMed/NCBI

Møller RS, Wuttke TV, Helbig I, Marini C, Johannesen KM, Brilstra EH, Vaher U, Borggraefe I, Talvik I, Talvik T, et al: Mutations in GABRB3: From febrile seizures to epileptic encephalopathies. Neurology. 88:483–492. 2017. View Article : Google Scholar : PubMed/NCBI

Johannesen KM, Gardella E, Linnankivi T, Courage C, de Saint Martin A, Lehesjoki AE, Mignot C, Afenjar A, Lesca G, Abi-Warde MT, et al: Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia. 59:389–402. 2018. View Article : Google Scholar : PubMed/NCBI

Ortega-Moreno L, Giráldez BG, Soto-Insuga V, Losada-Del Pozo R, Rodrigo-Moreno M, Alarcón-Morcillo C, Sánchez- Martín G, Díaz-Gómez E, Guerrero-López R, Serratosa JM, et al: Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes. PLoS One. 12:e01889782017. View Article : Google Scholar : PubMed/NCBI

Steinlein OK: Gene polymorphisms and their role in epilepsy treatment and prognosis. Naunyn Schmiedebergs Arch Pharmacol. 382:109–118. 2010. View Article : Google Scholar : PubMed/NCBI

Esmaeilzadeh H, Farjadian S, Alyasin S, Nemati H, Nabavizadeh H and Esmaeilzadeh E: Epidemiology of severe cutaneous adverse drug reaction and its HLA association among pediatrics. Iran J Pharm Res. 18:506–522. 2019.PubMed/NCBI

Yang X, Yan Y, Fang S, Zeng S, Ma H, Qian L, Chen X, Wei J, Gong Z and Xu Z: Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms. Medicine (Baltimore). 98:e149082019. View Article : Google Scholar : PubMed/NCBI

Huang J, Qian Z, Chen H, Huang Q, Huang L, Liu G and Tang X: Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 36:271–274. 2019.(In Chinese). PubMed/NCBI

Shi L, Zhu M, Li H, Wen Z, Chen X, Luo J, Lin C and Zhang Z: SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients. Eur J Clin Pharmacol. 75:655–663. 2019. View Article : Google Scholar : PubMed/NCBI

Feng W, Mei S, Han J, Zhu L, Yu Y, Gao B, Wu Y, Li J, Zhao Z and Fang F: Lack of association between valproic acid response and polymorphisms of its metabolism, transport, and receptor genes in children with focal seizures. Neurol Sci. 40:523–528. 2019. View Article : Google Scholar : PubMed/NCBI

Suzuki T, Mihara K, Nagai G, Kagawa S, Nakamura A, Nemoto K and Kondo T: Relationship between UGT1A4 and UGT2B7 polymorphisms and the steady-state plasma concentrations of lamotrigine in patients with treatment-resistant depressive disorder receiving lamotrigine as augmentation therapy. Ther Drug Monit. 41:86–90. 2019. View Article : Google Scholar : PubMed/NCBI

Li Z and Wang Y: Relationship between UGT1A4 142T>G polymorphism and serum concentration of lamotrigine in Chinese epileptic patients: A meta-analysis. Zhonghua Yi Xue Za Zhi. 98:3365–3370. 2018.(In Chinese). PubMed/NCBI

Gailite L, Rots D, Pukite I, Cernevska G and Kreile M: Case report: Multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome. BMC Pediatr. 18:3172018. View Article : Google Scholar : PubMed/NCBI

Feng W, Mei S, Zhu L, Yu Y, Yang W, Gao B, Wu X, Zhao Z and Fang F: Effects of UGT2B7, SCN1A and CYP3A4 on the therapeutic response of sodium valproate treatment in children with generalized seizures. Seizure. 58:96–100. 2018. View Article : Google Scholar : PubMed/NCBI

Liu L, Zhao L, Wang Q, Qiu F, Wu X and Ma Y: Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7-161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Eur J Clin Pharmacol. 71:1341–1347. 2015. View Article : Google Scholar : PubMed/NCBI

Sun YX, Zhuo WY, Lin H, Peng ZK, Wang HM, Huang HW, Luo YH and Tang FQ: The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients. Epilepsy Res. 114:78–80. 2015. View Article : Google Scholar : PubMed/NCBI

Kousar S, Wafai ZA, Wani MA, Jan TR and Andrabi KI: Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: Validatory pharmacogenomic approach to pharmacovigilance. Int J Clin Pharmacol Ther. 53:504–516. 2015. View Article : Google Scholar : PubMed/NCBI

Zhu X, Yun W, Sun X, Qiu F, Zhao L and Guo Y: Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. Pharmacogenomics. 15:1867–1879. 2014. View Article : Google Scholar : PubMed/NCBI

Reimers A, Sjursen W, Helde G and Brodtkorb E: Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine. Eur J Drug Metab Pharmacokinet. 41:149–155. 2016. View Article : Google Scholar : PubMed/NCBI

Berghuis B, Stapleton C, Sonsma ACM, Hulst J, de Haan GJ, Lindhout D, Demurtas R, EpiPGX Consortium, Krause R, Depondt C, et al: A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. Epilepsia Open. 4:102–109. 2019. View Article : Google Scholar : PubMed/NCBI

Berghuis B, van der Palen J, de Haan GJ, Lindhout D, Koeleman BPC and Sander JW; EpiPGX Consortium, : Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia. 58:1227–1233. 2017. View Article : Google Scholar : PubMed/NCBI

McCormack M, Gui H, Ingason A, Speed D, Wright GEB, Zhang EJ, Secolin R, Yasuda C, Kwok M, Wolking S, et al: Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients. Neurology. 90:e332–e341. 2018. View Article : Google Scholar : PubMed/NCBI

Bai X, Xu C, Wen D, Chen Y, Li H, Wang X, Zhou L, Huang M and Jin J: Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients. Psychopharmacology (Berl). 235:2665–2673. 2018. View Article : Google Scholar : PubMed/NCBI

Li H, Wang X, Zhou Y, Ni G, Su Q, Chen Z, Chen Z, Li J, Chen X, Hou X, et al: Association of LEPR and ANKK1 gene polymorphisms with weight gain in epilepsy patients receiving valproic acid. Int J Neuropsychopharmacol. 18:pyv0212015. View Article : Google Scholar : PubMed/NCBI

Wang C, Wang P, Yang LP, Pan J, Yang X and Ma HY: Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy. Epilepsy Res. 132:64–69. 2017. View Article : Google Scholar : PubMed/NCBI

Manna I, Gambardella A, Bianchi A, Striano P, Tozzi R, Aguglia U, Beccaria F, Benna P, Campostrini R, Canevini MP, et al: A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. Epilepsia. 52:e40–e44. 2011. View Article : Google Scholar : PubMed/NCBI

Kothur K, Holman K, Farnsworth E, Ho G, Lorentzos M, Troedson C, Gupta S, Webster R, Procopis PG, Menezes MP, et al: Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy. Seizure. 59:132–140. 2018. View Article : Google Scholar : PubMed/NCBI

Fang ZX, Zhang M, Xie LL, Jiang L, Hong SQ, Li XJ, Hu Y and Chen J: KCNQ2 related early-onset epileptic encephalopathies in Chinese children. J Neurol. 266:2224–2232. 2019. View Article : Google Scholar : PubMed/NCBI

Goto A, Ishii A, Shibata M, Ihara Y, Cooper EC and Hirose S: Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy. Epilepsia. 60:1870–1880. 2019. View Article : Google Scholar : PubMed/NCBI

Kuersten M, Tacke M, Gerstl L, Hoelz H, Stülpnagel CV and Borggraefe I: Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review. Eur J Med Genet. 63:1036282020. View Article : Google Scholar : PubMed/NCBI

Al-Eitan LN, Al-Dalalah IM, Elshammari AK, Khreisat WH and Almasri AY: The impact of potassium channel gene polymorphisms on antiepileptic drug responsiveness in Arab patients with epilepsy. J Pers Med. 8(pii): E372018. View Article : Google Scholar : PubMed/NCBI

Howell KB, McMahon JM, Carvill GL, Tambunan D, Mackay MT, Rodriguez-Casero V, Webster R, Clark D, Freeman JL, Calvert S, et al: SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures. Neurology. 85:958–966. 2015. View Article : Google Scholar : PubMed/NCBI

Turkdogan D, Thomas G and Demirel B: Ketogenic diet as a successful early treatment modality for SCN2A mutation. Brain Dev. 41:389–391. 2019. View Article : Google Scholar : PubMed/NCBI

Li X, Zhang J, Wu X, Yan H, Zhang Y, He RH, Tang YJ, He YJ, Tan D, Mao XY, et al: Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese. Pharmacogenomics. 17:2007–2014. 2016. View Article : Google Scholar : PubMed/NCBI

Al-Eitan LN, Al-Dalalah IM and Aljamal HA: Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility. Saudi Pharm J. 27:731–737. 2019. View Article : Google Scholar : PubMed/NCBI

Demarest ST and Brooks-Kayal A: From molecules to medicines: The dawn of targeted therapies for genetic epilepsies. Nat Rev Neurol. 14:735–745. 2018. View Article : Google Scholar : PubMed/NCBI

Murray S, Labbé S, Kothare S, Málaga I, Kluger G, Ogden P, Lazure P and Arzimanoglou A: Identifying the educational needs of physicians in pediatric epilepsy in order to improve care: Results from a needs assessment in Germany, Spain, and the United States. Epileptic Disord. 20:239–256. 2018.PubMed/NCBI

Striano P, Vari MS, Mazzocchetti C, Verrotti A and Zara F: Management of genetic epilepsies: From empirical treatment to precision medicine. Pharmacol Res. 107:426–429. 2016. View Article : Google Scholar : PubMed/NCBI

Sánchez Alvarez JC, Serrano Castro PJ and Serratosa Fernández JM: Clinical implications of mechanisms of resistance to antiepileptic drugs. Neurologist. 13 (Suppl 1):S38–S46. 2007. View Article : Google Scholar : PubMed/NCBI

Cardenas-Rodriguez N, Huerta-Gertrudis B, Rivera-Espinosa L, Montesinos-Correa H, Bandala C, Carmona-Aparicio L and Coballase-Urrutia E: Role of oxidative stress in refractory epilepsy: Evidence in patients and experimental models. Int J Mol Sci. 14:1455–1476. 2013. View Article : Google Scholar : PubMed/NCBI

Trivisano M, Terracciano A, Milano T, Cappelletti S, Pietrafusa N, Bertini ES, Vigevano F and Specchio N: Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy. Epilepsia. 56:e53–e57. 2015. View Article : Google Scholar : PubMed/NCBI

Wang MY, Liu XZ, Wang J and Wu LW: A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in a Chinese patient with non-familial nocturnal frontal lobe epilepsy. Epilepsy Res. 108:1927–1931. 2014. View Article : Google Scholar : PubMed/NCBI

Villa C, Colombo G, Meneghini S, Gotti C, Moretti M, Ferini-Strambi L, Chisci E, Giovannoni R, Becchetti A and Combi R: CHRNA2 and nocturnal frontal lobe epilepsy: Identification and characterization of a novel loss of function mutation. Front Mol Neurosci. 12:172019. View Article : Google Scholar : PubMed/NCBI

Goldberg-Stern H, Kaufmann R, Kivity S, Afawi Z and Heron SE: Novel mutation in KCNQ2 causing benign familial neonatal seizures. Pediatr Neurol. 41:367–370. 2009. View Article : Google Scholar : PubMed/NCBI

Chen DY, Chowdhury S, Farnaes L, Friedman JR, Honold J, Dimmock DP and Gold OBOTRIJJ: Rapid diagnosis of KCNQ2-associated early infantile epileptic encephalopathy improved outcome. Pediatr Neurol. 86:69–70. 2018. View Article : Google Scholar : PubMed/NCBI

Allen NM, Mannion M, Conroy J, Lynch SA, Shahwan A, Lynch B and King MD: The variable phenotypes of KCNQ-related epilepsy. Epilepsia. 55:e99–e105. 2014. View Article : Google Scholar : PubMed/NCBI

Piro E, Nardello R, Gennaro E, Fontana A, Taglialatela M, Donato Mangano G, Corsello G and Mangano S: A novel mutation in KCNQ3-related benign familial neonatal epilepsy: Electroclinical features and neurodevelopmental outcome. Epileptic Disord. 21:87–91. 2019.PubMed/NCBI

Miceli F, Striano P, Soldovieri MV, Fontana A, Nardello R, Robbiano A, Bellini G, Elia M, Zara F, Taglialatela M and Mangano S: A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. Epilepsia. 56:e15–e20. 2015. View Article : Google Scholar : PubMed/NCBI

Lehman A, Thouta S, Mancini GMS, Naidu S, van Slegtenhorst M, McWalter K, Person R, Mwenifumbo J, Salvarinova R; CAUSES Study, ; et al: Loss-of-function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy. Am J Hum Genet. 101:65–74. 2017. View Article : Google Scholar : PubMed/NCBI

Krepischi AC, Knijnenburg J, Bertola DR, Kim CA, Pearson PL, Bijlsma E, Szuhai K, Kok F, Vianna-Morgante AM and Rosenberg C: Two distinct regions in 2q24.2-q24.3 associated with idiopathic epilepsy. Epilepsia. 51:2457–2460. 2010. View Article : Google Scholar : PubMed/NCBI

Liang JS, Lin LJ, Yang MT, Wang JS and Lu JF: The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features. Brain Dev. 39:877–881. 2017. View Article : Google Scholar : PubMed/NCBI

Davidsson J, Collin A, Olsson ME, Lundgren J and Soller M: Deletion of the SCN gene cluster on 2q24.4 is associated with severe epilepsy: An array-based genotype-phenotype correlation and a comprehensive review of previously published cases. Epilepsy Res. 81:69–79. 2008. View Article : Google Scholar : PubMed/NCBI

Zaman T, Helbig I, Bozovic IB, DeBrosse SD, Bergqvist AC, Wallis K, Medne L, Maver A, Peterlin B, Helbig KL, et al: Mutations in SCN3A cause early infantile epileptic encephalopathy. Ann Neurol. 83:703–717. 2018. View Article : Google Scholar : PubMed/NCBI

Yang Y, Zhang YH, Chen JY, Zhang J, Yang XL, Chen Y, Yang ZX and Wu XR: Clinical features of epilepsies associated with GABRB2 variants. Zhonghua Er Ke Za Zhi. 57:532–537. 2019.(In Chinese). PubMed/NCBI

Butler KM, Moody OA, Schuler E, Coryell J, Alexander JJ, Jenkins A and Escayg A: De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain. 141:2392–2405. 2018. View Article : Google Scholar : PubMed/NCBI

Orenstein N, Goldberg-Stern H, Straussberg R, Bazak L, Hubshman MW, Kropach N, Gilad O, Scheuerman O, Dory Y, Kraus D, et al: A de novo GABRA2 missense mutation in severe early-onset epileptic encephalopathy with a choreiform movement disorder. Eur J Paediatr Neurol. 22:516–524. 2018. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Lian Y and Xie N: Early onset epileptic encephalopathy with a novel GABRB3 mutation treated effectively with clonazepam: A case report. Medicine (Baltimore). 96:e92732017. View Article : Google Scholar : PubMed/NCBI

Hernandez CC, Zhang Y, Hu N, Shen D, Shen W, Liu X, Kong W, Jiang Y and Macdonald RL: GABA a receptor coupling junction and pore GABRB3 mutations are linked to early-onset epileptic encephalopathy. Sci Rep. 7:159032017. View Article : Google Scholar : PubMed/NCBI

Farnaes L, Nahas SA, Chowdhury S, Nelson J, Batalov S, Dimmock DM and Kingsmore SF; RCIGM Investigators, : Rapid whole-genome sequencing identifies a novel GABRA1 variant associated with West syndrome. Cold Spring Harb Mol Case Stud. 3(pii): a0017762017. View Article : Google Scholar : PubMed/NCBI

Iqbal MJ, Wasim M, Rashid U, Zeeshan N, Ali R, Nayyab S, Habib S, Manzoor B and Zahid N: Mutational screening of GABRG2 gene in Pakistani population of Punjab with generalized tonic clonic seizures and children with childhood absence epilepsy. J Chin Med Assoc. 81:665–669. 2018. View Article : Google Scholar : PubMed/NCBI

Bhat MA, Guru SA, Mir R, Waza AA, Zuberi M, Sumi MP, Bodeliwala S, Puri V and Saxena A: Association of GABAA receptor gene with epilepsy syndromes. J Mol Neurosci. 65:141–153. 2018. View Article : Google Scholar : PubMed/NCBI

Le SV, Le PHT, Le TKV, Huynh TTK and Do TTH: A mutation in GABRB3 associated with Dravet syndrome. Am J Med Genet A. 173:2126–2131. 2017. View Article : Google Scholar : PubMed/NCBI

Ishii A, Kang JQ, Schornak CC, Hernandez CC, Shen W, Watkins JC, Macdonald RL and Hirose S: A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J Med Genet. 54:202–211. 2017. View Article : Google Scholar : PubMed/NCBI

Yoo Y, Jung J, Lee YN, Lee Y, Cho H, Na E, Hong J, Kim E, Lee JS, Lee JS, et al: GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy. Ann Neurol. 82:466–478. 2017. View Article : Google Scholar : PubMed/NCBI

Epi4K Consortium: De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies. Am J Hum Genet. 99:287–298. 2016. View Article : Google Scholar : PubMed/NCBI

Liu J, Tong L, Song S, Niu Y, Li J, Wu X, Zhang J, Zai CC, Luo F, Wu J, et al: Novel and de novo mutations in pediatric refractory epilepsy. Mol Brain. 11:482018. View Article : Google Scholar : PubMed/NCBI

Hayashida T, Saito Y, Ishii A, Yamada H, Itakura A, Minato T, Fukuyama T, Maegaki Y and Hirose S: CACNA1A-related early-onset encephalopathy with myoclonic epilepsy: A case report. Brain Dev. 40:130–133. 2018. View Article : Google Scholar : PubMed/NCBI

Byers HM, Beatty CW, Hahn SH and Gospe SM Jr: Dramatic response after lamotrigine in a patient with epileptic encephalopathy and a de novo CACNA1A variant. Pediatr Neurol. 60:79–82. 2016. View Article : Google Scholar : PubMed/NCBI

Epperson MV, Haws ME, Standridge SM and Gilbert DL: An atypical rett syndrome phenotype due to a novel missense mutation in CACNA1A. J Child Neurol. 33:286–289. 2018. View Article : Google Scholar : PubMed/NCBI

Du X, Chen Y, Zhao Y, Luo W, Cen Z and Hao W: Dramatic response to pyridoxine in a girl with absence epilepsy with ataxia caused by a de novo CACNA1A mutation. Seizure. 45:189–191. 2017. View Article : Google Scholar : PubMed/NCBI

Heron SE, Khosravani H, Varela D, Bladen C, Williams TC, Newman MR, Scheffer IE, Berkovic SF, Mulley JC and Zamponi GW: Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol. 62:560–568. 2007. View Article : Google Scholar : PubMed/NCBI

Yoshida M, Nakashima M, Okanishi T, Kanai S, Fujimoto A, Itomi K, Morimoto M, Saitsu H, Kato M, Matsumoto N and Chiyonobu T: Identification of novel BCL11A variants in patients with epileptic encephalopathy: Expanding the phenotypic spectrum. Clin Genet. 93:368–373. 2018. View Article : Google Scholar : PubMed/NCBI

Kurian M, Korff CM, Ranza E, Bernasconi A, Lübbig A, Nangia S, Ramelli GP, Wohlrab G, Nordli DR and Bast T: Focal cortical malformations in children with early infantile epilepsy and PCDH19 mutations: Case report. Dev Med Child Neurol. 60:100–105. 2018. View Article : Google Scholar : PubMed/NCBI

Ko A, Youn SE, Kim SH, Lee JS, Kim S, Choi JR, Kim HD, Lee ST and Kang HC: Targeted gene panel and genotype- phenotype correlation in children with developmental and epileptic encephalopathy. Epilepsy Res. 141:48–55. 2018. View Article : Google Scholar : PubMed/NCBI

Wang ZJ, Chen J, Chen HL, Zhang LY, Xu D and Jiang WT: Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: A case-control study and meta-analysis. Biosci Rep. 38(pii): BSR201816542018. View Article : Google Scholar : PubMed/NCBI

Margari L, Legrottaglie AR, Vincenti A, Coppola G, Operto FF, Buttiglione M, Cassano A, Bartolomeo N and Mariggio MA: Association between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patients. Seizure. 55:30–35. 2018. View Article : Google Scholar : PubMed/NCBI

Ajmi M, Boujaafar S, Zouari N, Amor D, Nasr A, Rejeb NB, Amor SB, Omezzine A, Benammou S and Bouslama A: Association between ABCB1 polymorphisms and response to first-generation antiepileptic drugs in a Tunisian epileptic population. Int J Neurosci. 128:705–714. 2018. View Article : Google Scholar : PubMed/NCBI

Abou El Ella SS, Tawfik MA, Abo El Fotoh WMM and Soliman OAM: The genetic variant ‘C588T’ of GABARG2 is linked to childhood idiopathic generalized epilepsy and resistance to antiepileptic drugs. Seizure. 60:39–43. 2018. View Article : Google Scholar : PubMed/NCBI

Skalski D, Wendorff J, Romanowicz H, Rysz A, Marchel A, Stasiołek M and Smolarz B: Associations between MDR1 C3435T polymorphism and drug-resistant epilepsy in the Polish population. Acta Neurol Belg. 117:153–158. 2017. View Article : Google Scholar : PubMed/NCBI

López-Garcia MA, Feria-Romero IA, Serrano H, Rayo-Mares D, Fagiolino P, Vázquez M, Escamilla-Núñez C, Grijalva I, Escalante-Santiago D and Orozco-Suarez S: Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy. Pharmacol Rep. 69:504–511. 2017. View Article : Google Scholar

Lv Y, Wang Z, Liu C and Cui L: Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy. Neuropsychiatr Dis Treat. 13:2631–2636. 2017. View Article : Google Scholar : PubMed/NCBI

Kozera-Kępniak A, Jastrzębski K, Walenczak J, Klimek A and Głąbiński A: 66034T/C polymorphism of the human pregnane X receptor (hPXR) as potential risk factor for drug resistance in epilepsy-Preliminary study. Neurol Neurochir Pol. 51:19–23. 2017. View Article : Google Scholar : PubMed/NCBI

Wang J, Gao H, Bao X, Zhang Q, Li J, Wei L, Wu X, Chen Y and Yu S: SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures. BMC Med Genet. 18:1042017. View Article : Google Scholar : PubMed/NCBI

Parrini E, Marini C, Mei D, Galuppi A, Cellini E, Pucatti D, Chiti L, Rutigliano D, Bianchini C, Virdo S, et al: Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes. Hum Mutat. 38:216–225. 2017. View Article : Google Scholar : PubMed/NCBI

Kimizu T, Takahashi Y, Oboshi T, Horino A, Koike T, Yoshitomi S, Mori T, Yamaguchi T, Ikeda H, Okamoto N, et al: A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy. Brain Dev. 39:256–260. 2017. View Article : Google Scholar : PubMed/NCBI

Shen D, Hernandez CC, Shen W, Hu N, Poduri A, Shiedley B, Rotenberg A, Datta AN, Leiz S, Patzer S, et al: De novo GABRG2 mutations associated with epileptic encephalopathies. Brain. 140:49–67. 2017. View Article : Google Scholar : PubMed/NCBI

Zhang Q, Li J, Zhao Y, Bao X, Wei L and Wang J: Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy. Clin Genet. 91:717–724. 2017. View Article : Google Scholar : PubMed/NCBI

Miao P, Peng J, Chen C, Gai N and Yin F: A novel mutation in KCNB1 gene in a child with neuropsychiatric comorbidities with both intellectual disability and epilepsy and review of literature. Zhonghua Er Ke Za Zhi. 55:115–119. 2017.(In Chinese). PubMed/NCBI

Perucca P, Scheffer IE, Harvey AS, James PA, Lunke S, Thorne N, Gaff C, Regan BM, Damiano JA, Hildebrand MS, et al: Real-world utility of whole exome sequencing with targeted gene analysis for focal epilepsy. Epilepsy Res. 131:1–8. 2017. View Article : Google Scholar : PubMed/NCBI

Guo M, Wang J, Qi H, Liu F, Yao L, Zhang S and Li K: Polymorphisms in the receptor for advanced glycation end products gene are associated with susceptibility to drug-resistant epilepsy. Neurosci Lett. 619:137–141. 2016. View Article : Google Scholar : PubMed/NCBI

Stasiołek M, Romanowicz H, Połatyńska K, Chamielec M, Skalski D, Makowska M and Smolarz B: Association between C3435T polymorphism of MDR1 gene and the incidence of drug-resistant epilepsy in the population of Polish children. Behav Brain Funct. 12:212016. View Article : Google Scholar : PubMed/NCBI

Abo El Fotoh WM, Abd El Naby SA, Habib MS, ALrefai AA and Kasemy ZA: The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children. Seizure. 41:75–80. 2016. View Article : Google Scholar : PubMed/NCBI

Xue T and Lu ZN: Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population. Genet Mol Res. 15:2016. View Article : Google Scholar :

Moen MN, Fjaer R, Hamdani EH, Laerdahl JK, Menchini RJ, Vigeland MD, Sheng Y, Undlien DE, Hassel B, Salih MA, et al: Pathogenic variants in KCTD7 perturb neuronal K⁺ fluxes and glutamine transport. Brain. 139:3109–3120. 2016. View Article : Google Scholar : PubMed/NCBI

Hildebrand MS, Griffin NG, Damiano JA, Cops EJ, Burgess R, Ozturk E, Jones NC, Leventer RJ, Freeman JL, Harvey AS, et al: Mutations of the sonic hedgehog pathway underlie hypothalamic hamartoma with gelastic epilepsy. Am J Hum Genet. 99:423–429. 2016. View Article : Google Scholar : PubMed/NCBI

Hardies K, Cai Y, Jardel C, Jansen AC, Cao M, May P, Djémié T, Hachon Le Camus C, Keymolen K, Deconinck T, et al: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline. Brain. 139:2420–2430. 2016. View Article : Google Scholar : PubMed/NCBI

Lionel AC, Monfared N, Scherer SW, Marshall CR and Mercimek-Mahmutoglu S: MED23-associated refractory epilepsy successfully treated with the ketogenic diet. Am J Med Genet A. 170:2421–2425. 2016. View Article : Google Scholar : PubMed/NCBI

Balestrini S, Milh M, Castiglioni C, Lüthy K, Finelli MJ, Verstreken P, Cardon A, Stražišar BG, Holder JL Jr, Lesca G, et al: TBC1D24 genotype-phenotype correlation: Epilepsies and other neurologic features. Neurology. 87:77–85. 2016. View Article : Google Scholar : PubMed/NCBI

Fahrner JA, Liu R, Perry MS, Klein J and Chan DC: A novel de novo dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy. Am J Med Genet A. 170:2002–2011. 2016. View Article : Google Scholar : PubMed/NCBI

Vanstone JR, Smith AM, McBride S, Naas T, Holcik M, Antoun G, Harper ME, Michaud J, Sell E, Chakraborty P, et al: DNM1L-related mitochondrial fission defect presenting as refractory epilepsy. Eur J Hum Genet. 24:1084–1088. 2016. View Article : Google Scholar : PubMed/NCBI

Janssen W, Quaegebeur A, Van Goethem G, Ann L, Smets K, Vandenberghe R and Van Paesschen W: The spectrum of epilepsy caused by POLG mutations. Acta Neurol Belg. 116:17–25. 2016. View Article : Google Scholar : PubMed/NCBI

Li D, Yuan H, Ortiz-Gonzalez XR, Marsh ED, Tian L, McCormick EM, Kosobucki GJ, Chen W, Schulien AJ, Chiavacci R, et al: GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers. Am J Hum Genet. 99:802–816. 2016. View Article : Google Scholar : PubMed/NCBI

Segal E, Pedro H, Valdez-Gonzalez K, Parisotto S, Gliksman F, Thompson S, Sabri J and Fertig E: Diagnostic yield of epilepsy panels in children with medication-refractory epilepsy. Pediatr Neurol. 64:66–71. 2016. View Article : Google Scholar : PubMed/NCBI

Palmer S, Towne MC, Pearl PL, Pelletier RC, Genetti CA, Shi J, Beggs AH, Agrawal PB and Brownstein CA: SLC6A1 mutation and ketogenic diet in epilepsy with myoclonic-atonic seizures. Pediatr Neurol. 64:77–79. 2016. View Article : Google Scholar : PubMed/NCBI

Inui T, Kobayashi S, Ashikari Y, Sato R, Endo W, Uematsu M, Oba H, Saitsu H, Matsumoto N, Kure S and Haginoya K: Two cases of early-onset myoclonic seizures with continuous parietal delta activity caused by EEF1A2 mutations. Brain Dev. 38:520–524. 2016. View Article : Google Scholar : PubMed/NCBI

Horta WG, Paradela E, Figueiredo A, Meira ID, Pereira VC, Rego CC, Oliveira R, Andraus ME, de Lacerda GC, Moura P, et al: Genetic association study of the HLA class II alleles DRB1, DQA1, and DQB1 in patients with pharmacoresistant temporal lobe epilepsy associated with mesial hippocampal sclerosis. Seizure. 31:7–11. 2015. View Article : Google Scholar : PubMed/NCBI

Damiano JA, Afawi Z, Bahlo M, Mauermann M, Misk A, Arsov T, Oliver KL, Dahl HH, Shearer AE, Smith RJ, et al: Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus epilepsy with early ataxia. Hum Mol Genet. 24:4483–4490. 2015. View Article : Google Scholar : PubMed/NCBI

Bene J, Hadzsiev K, Komlósi K, Kövesdi E, Mátyás P and Melegh B: De novo SCN1A gene deletion in therapy-resistant Dravet syndrome. Orv Hetil. 156:2009–2012. 2015.(In Hungarian). View Article : Google Scholar : PubMed/NCBI

Berghuis B, de Kovel CG, van Iterson L, Lamberts RJ, Sander JW, Lindhout D and Koeleman BP: Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy. Epilepsy Res. 115:141–144. 2015. View Article : Google Scholar : PubMed/NCBI

Damaj L, Lupien-Meilleur A, Lortie A, Riou É, Ospina LH, Gagnon L, Vanasse C and Rossignol E: CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet. 23:1505–1512. 2015. View Article : Google Scholar : PubMed/NCBI

Guo Y, Yan KP, Qu Q, Qu J, Chen ZG, Song T, Luo XY, Sun ZY, Bi CL and Liu JF: Common variants of KCNJ10 are associated with susceptibility and anti-epileptic drug resistance in Chinese genetic generalized epilepsies. PLoS One. 10:e01248962015. View Article : Google Scholar : PubMed/NCBI

Liu Z, Yin X, Liu L, Tao H, Zhou H, Ma G, Cui L, Li Y, Zhang S, Xu Z, et al: Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy. Gene. 571:231–236. 2015. View Article : Google Scholar : PubMed/NCBI

Emich-Widera E, Likus W, Kazek B, Sieron AL and Urbanek K: Polymorphism of ABCB1/MDR1 C3435T in children and adolescents with partial epilepsy is due to different criteria for drug resistance-preliminary results. Med Sci Monit. 20:1654–1661. 2014. View Article : Google Scholar : PubMed/NCBI

Venkateswaran S, Myers KA, Smith AC, Beaulieu CL, Schwartzentruber JA; FORGE Canada Consortium, ; Majewski J, Bulman D, Boycott KM and Dyment DA: Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation. Epilepsia. 55:e75–e79. 2014. View Article : Google Scholar : PubMed/NCBI

Picard F, Makrythanasis P, Navarro V, Ishida S, de Bellescize J, Ville D, Weckhuysen S, Fosselle E, Suls A, De Jonghe P, et al: DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 82:2101–2106. 2014. View Article : Google Scholar : PubMed/NCBI

Martin HC, Kim GE, Pagnamenta AT, Murakami Y, Carvill GL, Meyer E, Copley RR, Rimmer A, Barcia G, Fleming MR, et al: Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. Hum Mol Genet. 23:3200–3211. 2014. View Article : Google Scholar : PubMed/NCBI

Seven M, Batar B, Unal S, Yesil G, Yuksel A and Guven M: The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children. Mol Biol Rep. 41:331–336. 2014. View Article : Google Scholar : PubMed/NCBI

Escalante-Santiago D, Feria-Romero IA, Ribas-Aparicio RM, Rayo-Mares D, Fagiolino P, Vázquez M, Escamilla-Núñez C, Grijalva-Otero I, López-Garcia MA and Orozco-Suárez S: MDR-1 and MRP2 gene polymorphisms in mexican epileptic pediatric patients with complex partial seizures. Front Neurol. 5:1842014. View Article : Google Scholar : PubMed/NCBI

Seven M, Batar B, Unal S, Yesil G, Yuksel A and Guven M: The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children. Mol Diagn Ther. 18:229–236. 2014. View Article : Google Scholar : PubMed/NCBI

Ma CL, Wu XY, Zheng J, Wu ZY, Hong Z and Zhong MK: Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. Pharmacogenomics. 15:1323–1336. 2014. View Article : Google Scholar : PubMed/NCBI

He X, Li Y, Liu Z, Yue X, Zhao P, Hu J, Wu G, Mao B, Sun D, Zhang H, et al: The association between CCL2 polymorphisms and drug-resistant epilepsy in Chinese children. Epileptic Disord. 15:272–277. 2013. View Article : Google Scholar : PubMed/NCBI

Serino D, Specchio N, Pontrelli G, Vigevano F and Fusco L: Video/EEG findings in a KCNQ2 epileptic encephalopathy: A case report and revision of literature data. Epileptic Disord. 15:158–165. 2013.PubMed/NCBI

Emich-Widera E, Likus W, Kazek B, Niemiec P, Balcerzyk A, Sieroń AL and Zak I: CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents. Biomed Res Int. 2013:5268372013. View Article : Google Scholar : PubMed/NCBI

Veeramah KR, Johnstone L, Karafet TM, Wolf D, Sprissler R, Salogiannis J, Barth-Maron A, Greenberg ME, Stuhlmann T, Weinert S, et al: Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 54:1270–1281. 2013. View Article : Google Scholar : PubMed/NCBI

Fragaki K, Ait-El-Mkadem S, Chaussenot A, Gire C, Mengual R, Bonesso L, Beneteau M, Ricci JE, Desquiret-Dumas V, Procaccio V, et al: Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency. Eur J Hum Genet. 21:528–534. 2013. View Article : Google Scholar : PubMed/NCBI

Subenthiran S, Abdullah NR, Joseph JP, Muniandy PK, Mok BT, Kee CC, Ismail Z and Mohamed Z: Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital. PLoS One. 8:e648272013. View Article : Google Scholar : PubMed/NCBI

Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, Tang Q, Zhou HH and Liu ZQ: ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther. 18:647–651. 2012. View Article : Google Scholar : PubMed/NCBI

Dimova PS, Kirov A, Todorova A, Todorov T and Mitev V: A novel PCDH19 mutation inherited from an unaffected mother. Pediatr Neurol. 46:397–400. 2012. View Article : Google Scholar : PubMed/NCBI

Sayyah M, Kamgarpour F, Maleki M, Karimipoor M, Gharagozli K and Shamshiri AR: Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients. Epileptic Disord. 13:155–165. 2011. View Article : Google Scholar : PubMed/NCBI

Lakhan R, Kumari R, Singh K, Kalita J, Misra UK and Mittal B: Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy. Indian J Med Res. 134:295–301. 2011.PubMed/NCBI

Kumari R, Lakhan R, Garg RK, Kalita J, Misra UK and Mittal B: Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population. Indian J Hum Genet. 17 (Suppl 1):S32–S40. 2011. View Article : Google Scholar : PubMed/NCBI

Kwan P, Wong V, Ng PW, Lui CH, Sin NC, Wong KS and Baum L: Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy. Pharmacogenomics. 12:319–325. 2011. View Article : Google Scholar : PubMed/NCBI

Kim DU, Kim MK, Cho YW, Kim YS, Kim WJ, Lee MG, Kim SE, Nam TS, Cho KH, Kim YO and Lee MC: Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance. J Hum Genet. 56:640–646. 2011. View Article : Google Scholar : PubMed/NCBI

Meng H, Guo G, Ren J, Zhou H, Ge Y and Guo Y: Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. Epilepsy Behav. 21:27–30. 2011. View Article : Google Scholar : PubMed/NCBI

Alpman A, Ozkinay F, Tekgul H, Gokben S, Pehlivan S, Schalling M and Ozkinay C: Multidrug resistance 1 (MDR1) gene polymorphisms in childhood drug-resistant epilepsy. J Child Neurol. 25:1485–1490. 2010. View Article : Google Scholar : PubMed/NCBI

Maleki M, Sayyah M, Kamgarpour F, Karimipoor M, Arab A, Rajabi A, Gharagozli K, Shamshiri AR and Shahsavand Ananloo E: Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients. Iran Biomed J. 14:89–96. 2010.PubMed/NCBI

Di Bonaventura C, Carni M, Diani E, Fattouch J, Vaudano EA, Egeo G, Pantano P, Maraviglia B, Bozzao L, Manfredi M, et al: Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1mutation: Electroclinical, genetic, and EEG/fMRI findings. Epilepsia. 50:2481–2486. 2009. View Article : Google Scholar : PubMed/NCBI

Jang SY, Kim MK, Lee KR, Park MS, Kim BC, Cho KH, Lee MC and Kim YS: Gene-to-gene interaction between sodium channel-related genes in determining the risk of antiepileptic drug resistance. J Korean Med Sci. 24:62–68. 2009. View Article : Google Scholar : PubMed/NCBI

Vahab SA, Sen S, Ravindran N, Mony S, Mathew A, Vijayan N, Nayak G, Bhaskaranand N, Banerjee M and Satyamoorthy K: Analysis of genotype and haplotype effects of ABCB1 (MDR1) polymorphisms in the risk of medically refractory epilepsy in an Indian population. Drug Metab Pharmacokinet. 24:255–260. 2009. View Article : Google Scholar : PubMed/NCBI

Kwan P, Wong V, Ng PW, Lui CH, Sin NC, Poon WS, Ng HK, Wong KS and Baum L: Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese. Pharmacogenomics. 10:723–732. 2009. View Article : Google Scholar : PubMed/NCBI

Kauffman MA, Consalvo D, Gonzalez-Morón D, Aguirre F, D'Alessio L and Kochen S: Serotonin transporter gene variation and refractory mesial temporal epilepsy with hippocampal sclerosis. Epilepsy Res. 85:231–234. 2009. View Article : Google Scholar : PubMed/NCBI

Lakhan R, Kumari R, Misra UK, Kalita J, Pradhan S and Mittal B: Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population. Br J Clin Pharmacol. 68:214–220. 2009. View Article : Google Scholar : PubMed/NCBI

Bahi-Buisson N, Nectoux J, Rosas-Vargas H, Milh M, Boddaert N, Girard B, Cances C, Ville D, Afenjar A, Rio M, et al: Key clinical features to identify girls with CDKL5 mutations. Brain. 131:2647–2661. 2008. View Article : Google Scholar : PubMed/NCBI

Kwan P, Poon WS, Ng HK, Kang DE, Wong V, Ng PW, Lui CH, Sin NC, Wong KS and Baum L: Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: Correlation among phenotype, genotype, and mRNA expression. Pharmacogenet Genom. 18:989–998. 2008. View Article : Google Scholar

Elia M, Falco M, Ferri R, Spalletta A, Bottitta M, Calabrese G, Carotenuto M, Musumeci SA, Lo Giudice M and Fichera M: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology. 71:997–999. 2008. View Article : Google Scholar : PubMed/NCBI

Abe T, Seo T, Ishitsu T, Nakagawa T, Hori M and Nakagawa K: Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br J Clin Pharmacol. 66:304–307. 2008. View Article : Google Scholar : PubMed/NCBI

Shahwan A, Murphy K, Doherty C, Cavalleri GL, Muckian C, Dicker P, McCarthy M, Kinirons P, Goldstein D and Delanty N: The controversial association of ABCB1 polymorphisms in refractory epilepsy: An analysis of multiple SNPs in an Irish population. Epilepsy Res. 73:192–198. 2007. View Article : Google Scholar : PubMed/NCBI

Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui AC, Yu E and Wong LK: Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav. 11:112–117. 2007. View Article : Google Scholar : PubMed/NCBI

Hung CC, Jen Tai J, Kao PJ, Lin MS and Liou HH: Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses. Pharmacogenomics. 8:1151–1158. 2007. View Article : Google Scholar : PubMed/NCBI

Leschziner GD, Jorgensen AL, Andrew T, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Balding DJ, Rogers J, Bentley DR, et al: The association between polymorphisms in RLIP76 and drug response in epilepsy. Pharmacogenomics. 8:1715–1722. 2007. View Article : Google Scholar : PubMed/NCBI

Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K and Nakagawa K: ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics. 7:551–561. 2006. View Article : Google Scholar : PubMed/NCBI

Hung CC, Tai JJ, Lin CJ, Lee MJ and Liou HH: Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics. 6:411–417. 2005. View Article : Google Scholar : PubMed/NCBI

Mills PB, Surtees RA, Champion MP, Beesley CE, Dalton N, Scambler PJ, Heales SJ, Briddon A, Scheimberg I, Hoffmann GF, et al: Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5′-phosphate oxidase. Hum Mol Genet. 14:1077–1086. 2005. View Article : Google Scholar : PubMed/NCBI

Buono RJ, Lohoff FW, Sander T, Sperling MR, O'Connor MJ, Dlugos DJ, Ryan SG, Golden GT, Zhao H, Scattergood TM, et al: Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility. Epilepsy Res. 58:175–183. 2004. View Article : Google Scholar : PubMed/NCBI

Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW and Sisodiya SM: Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 348:1442–1448. 2003. View Article : Google Scholar : PubMed/NCBI

Gambardella A, Manna I, Labate A, Chifari R, La Russa A, Serra P, Cittadella R, Bonavita S, Andreoli V, LePiane E, et al: GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology. 60:560–563. 2003. View Article : Google Scholar : PubMed/NCBI